CAS: 2289691-01-4
MYCi975
CAS:2289691-01-4
MYCi975 (NUCC-0200975) is an orally active inhibitor of MYC.
Formula:
C25H16Cl2F6N2O2
Purity:
99.3%
Color and Shape:
Solid
Molecular weight:
561.3
Ref: TM-T12133
| 1mg | 122.00 € | |
| 5mg | 276.00 € | |
| 10mg | 460.00 € | |
| 25mg | 761.00 € | |
| 50mg | 1,054.00 € | |
| 100mg | 1,425.00 € | |
| 500mg | 2,757.00 € | |
| 1ml*10 (DMSO) | 356.00 € |
Estimated delivery in United States, on Monday 6 May 2024
![4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol](https://static.cymitquimica.com/products/AN/thumb/AG01KL4V.jpg)
4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol
CAS:2289691-01-4
Formula:
C25H16Cl2F6N2O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
561.3032
Ref: AN-AG01KL4V
| 1g | 1,734.00 € | |
| 25mg | 187.00 € | |
| 50mg | 226.00 € | |
| 100mg | 508.00 € | |
| 250mg | 609.00 € |
Estimated delivery in United States, on Monday 6 May 2024
MYCi975
CAS:2289691-01-4
MYCi975 is a drug candidate in the development of cancer-targeted therapies. MYCi975 binds to and …
Formula:
C25H16Cl2F6N2O2
Purity:
Min. 95%
Molecular weight:
561.3 g/mol
Ref: 3D-PRD69101
| 1mg | 92.00 € | |
| 5mg | 240.00 € | |
| 10mg | 360.00 € | |
| 25mg | 601.00 € | |
| 50mg | 915.00 € |
Estimated delivery in United States, on Friday 17 May 2024
